Sino Medical Sciences Technology In (688108) — Tangible Net Worth Ratio
Sino Medical Sciences Technology In (688108) has a Tangible Net Worth Ratio of 46.7% as of June 2026. This metric is calculated by deducting intangible assets (CN¥571.18 Million) from net assets (CN¥1.07 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore how fast is Sino Medical Sciences Technology In growing its equity to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Sino Medical Sciences Technology In Tangible Net Worth Ratio (2016–2025)
This chart shows how Sino Medical Sciences Technology In's Tangible Net Worth Ratio has changed across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at 46.7%, reflecting net assets of CN¥1.07 Billion with intangible assets of CN¥571.18 Million CNY. For live market cap and overall valuation, see Sino Medical Sciences Technology In market capitalisation.
Annual Tangible Net Worth Ratio for Sino Medical Sciences Technology In (2016–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Sino Medical Sciences Technology In from 2016 to 2025, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Sino Medical Sciences Technology In (688108) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.4% | CN¥2.28 Billion | CN¥584.95 Million | CN¥1.35 Billion | ▲ +39.2 pp |
| 2024 | 35.2% | CN¥898.34 Million | CN¥582.39 Million | CN¥1.30 Billion | ▼ -20.9 pp |
| 2023 | 56.1% | CN¥861.65 Million | CN¥378.11 Million | CN¥1.19 Billion | ▼ -3.9 pp |
| 2022 | 60.1% | CN¥887.48 Million | CN¥354.50 Million | CN¥1.07 Billion | ▼ -6.7 pp |
| 2021 | 66.7% | CN¥945.16 Million | CN¥314.47 Million | CN¥1.10 Billion | ▼ -5.2 pp |
| 2020 | 72.0% | CN¥1.08 Billion | CN¥302.04 Million | CN¥1.22 Billion | ▼ -4.6 pp |
| 2019 | 76.6% | CN¥1.10 Billion | CN¥257.52 Million | CN¥1.21 Billion | ▼ -0.1 pp |
| 2018 | 76.6% | CN¥701.28 Million | CN¥163.99 Million | CN¥806.10 Million | ▼ -4.5 pp |
| 2017 | 81.1% | CN¥606.70 Million | CN¥114.54 Million | CN¥710.33 Million | ▲ +18.2 pp |
| 2016 | 62.9% | CN¥202.75 Million | CN¥75.23 Million | CN¥280.81 Million | — |